Rani Therapeutics Holdings, Inc. (RANI) Tops Q3 EPS by 5c

Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) reported Q3 EPS of ($0.12), $0.05 better than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Rani Therapeutics Holdings, Inc. (RANI) click here.

You May Also Be Interested In

• US Tiger Securities Upgrades Circle Internet Group (CRCL) to Buy, 'anchored in our more constructive view on Bitcoin'
• Samsung Electronics Co Ltd. (005930:KS) (SSNLF) PT Raised to KRW550,000 at BofA Securities
• RxSight Inc. (RXST) PT Lowered to $6.50 at BofA Securities